Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-096910
Filing Date
2025-04-25
Accepted
2025-04-25 16:21:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d803807ddefa14a.htm DEFA14A 11243
2 GRAPHIC g803807page002.jpg GRAPHIC 278912
3 GRAPHIC g803807page003.jpg GRAPHIC 208047
  Complete submission text file 0001193125-25-096910.txt   683580
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32157 | Film No.: 25874442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)